Journal of Medicinal Chemistry · 2007 · 50 citations · 4 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyDrug DiscoveryMolecular PharmacologyCytotoxic ChemotherapyMicrotubule-associated ProteinsMicrotubule-targeting AgentsOncology PharmacologyBinding Affinity To TubulinColchicine Site BindingColchicine-binding Site LigandsDrug Binding Sites On TubulinDrug Efflux PumpsMultidrug Efflux PumpsTubulin Binding InhibitionTubulin Binding Sites
A series of 3-aroyl indazoles was synthesized. Modification of the C-7 position resulted in a significant structure-activity relationship (SAR) with acetylene modifications conferring unusual potency in a tumor cell cytotoxicity assay. The most potent compounds exceeded the activity of combretastatin A4 (CA-4), showing single digit nM IC50 values against all cell lines tested including those with known efflux resistance pumps. The inhibition of in vitro tubulin polymerization was comparable to CA-4, consistent with tubulin being the target for these compounds. Competition binding experiments employing [3H]colchicine and purified tubulins demonstrated that the compound specifically binds to the colchicine site.
4
Daniel A. Beauregard, RB Pedley, Sally A. Hill et al. · NMR in Biomedicine · 2002 · 65 citations · Full text
Medicine, Oncology, Pharmacology +12
New small-molecule tubulin inhibitors
Gerald Bacher, Thomas Beckers, Peter Emig et al. · Pure and Applied Chemistry · 2001 · 52 citations · Full text
Activity of MKT 077, a rhodacyanine dye, against human tumor colony-forming units
Thierry Petit, Elżbieta Izbicka, Richard Lawrence et al. · Anti-Cancer Drugs · 1999 · 38 citations
Medicine, Oncology, Pharmacology +8
Multidrug Resistance in Locally Advanced Breast Cancer
Can Atalay, İsmet Gürhan, Çiğdem Irkkan et al. · Tumor Biology · 2006 · 35 citations
Medicine, Oncology, Pharmacology +13